Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2150

1.

Secukinumab for patients failing previous TNFα-inhibitor therapy: results of a randomised open-label study (Signature).

Warren RB, Barker J, Finlay AY, Burden AD, Kirby B, Armendariz Y, Williams R, Hatchard C, Khare S, Griffiths CEM.

Br J Dermatol. 2019 Oct 18. doi: 10.1111/bjd.18623. [Epub ahead of print]

PMID:
31628677
2.

Microbe-host interplay in atopic dermatitis and psoriasis.

Fyhrquist N, Muirhead G, Prast-Nielsen S, Jeanmougin M, Olah P, Skoog T, Jules-Clement G, Feld M, Barrientos-Somarribas M, Sinkko H, van den Bogaard EH, Zeeuwen PLJM, Rikken G, Schalkwijk J, Niehues H, Däubener W, Eller SK, Alexander H, Pennino D, Suomela S, Tessas I, Lybeck E, Baran AM, Darban H, Gangwar RS, Gerstel U, Jahn K, Karisola P, Yan L, Hansmann B, Katayama S, Meller S, Bylesjö M, Hupé P, Levi-Schaffer F, Greco D, Ranki A, Schröder JM, Barker J, Kere J, Tsoka S, Lauerma A, Soumelis V, Nestle FO, Homey B, Andersson B, Alenius H.

Nat Commun. 2019 Oct 16;10(1):4703. doi: 10.1038/s41467-019-12253-y.

3.

Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myeloid Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease.

Montoro J, Ceberio I, Hilden P, Maloy MA, Barker J, Castro-Malaspina H, Dahi P, Koehne G, Perales MA, Ponce D, Sauter C, Shaffer B, Tamari R, Young JW, Giralt SA, O'Reilly RJ, Jakubowski AA, Papadopoulos EB.

Biol Blood Marrow Transplant. 2019 Oct 13. pii: S1083-8791(19)30659-7. doi: 10.1016/j.bbmt.2019.10.003. [Epub ahead of print]

PMID:
31618690
4.

Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience.

Lin A, Maloy M, Su Y, Bhatt V, DeRespiris L, Griffin M, Lau C, Proli A, Barker J, Shaffer B, Giralt SA, Jakubowski AA, Papadopoulos EB, Papanicolaou GA, Seo SK, Perales MA.

Transpl Infect Dis. 2019 Oct 4:e13187. doi: 10.1111/tid.13187. [Epub ahead of print]

PMID:
31585500
5.

Backbone Reactivity of Lithium β-Diketiminate (NacNac) Complexes with CO2 , tBuNCO and iPrNCO.

Gauld RM, McLellan R, Kennedy AR, Barker J, Reid J, Mulvey RE.

Chemistry. 2019 Oct 1. doi: 10.1002/chem.201904013. [Epub ahead of print]

PMID:
31574177
6.

Validation of a Football Helmet Finite Element Model and Quantification of Impact Energy Distribution.

Corrales MA, Gierczycka D, Barker J, Bruneau D, Bustamante MC, Cronin DS.

Ann Biomed Eng. 2019 Sep 23. doi: 10.1007/s10439-019-02359-1. [Epub ahead of print]

PMID:
31549326
7.

Interleukin-36 promotes systemic Type-I IFN responses in severe forms of psoriasis.

Catapano M, Vergnano M, Romano M, Mahil SK, Choon SE, Burden AD, Young HS, Carr IM, Lachmann HJ, Lombardi G, Smith CH, Ciccarelli FD, Barker JN, Capon F.

J Invest Dermatol. 2019 Sep 17. pii: S0022-202X(19)33232-4. doi: 10.1016/j.jid.2019.08.444. [Epub ahead of print]

PMID:
31539532
8.

Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis.

Tsakok T, Wilson N, Dand N, Loeff FC, Bloem K, Baudry D, Duckworth M, Pan S, Pushpa-Rajah A, Standing JF, de Vries A, Alsharqi A, Becher G, Murphy R, Wahie S, Wright A, Griffiths CEM, Reynolds NJ, Barker J, Warren RB, Burden AD, Rispens T, Stocken D, Smith C; British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR) Study Group and the Psoriasis Stratification to Optimise Relevant Therapy (PSORT) Consortium.

JAMA Dermatol. 2019 Sep 18. doi: 10.1001/jamadermatol.2019.1783. [Epub ahead of print]

9.

Impact of bloom events on dissolved organic matter fluorophore signatures in Ohio waters.

Hipsher C, Barker J, MacKay A.

Sci Total Environ. 2019 Aug 22;699:134003. doi: 10.1016/j.scitotenv.2019.134003. [Epub ahead of print]

PMID:
31522052
10.

An Ion-Exchangeable MOF with Reversible Dehydration and Dynamic Structural Behavior (NH4 )2 [Zn2 (O3 PCH2 CH2 COO)2 ]⋅5 H2 O (BIRM-1).

Zhao C, Male L, Chen TY, Barker JA, Shannon IJ, Anderson PA.

Chemistry. 2019 Sep 5. doi: 10.1002/chem.201903230. [Epub ahead of print]

PMID:
31486553
11.

Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies.

Lin RJ, Elko TA, Devlin SM, Shahrokni A, Jakubowski AA, Dahi PB, Perales MA, Tamari R, Shaffer BC, Sauter CS, Papadopoulos EB, Gyurkocza B, Korc-Grodzicki B, Barker JN, Maloy MA, Giralt SA.

Bone Marrow Transplant. 2019 Aug 30. doi: 10.1038/s41409-019-0654-6. [Epub ahead of print]

PMID:
31471572
12.

Development of and recent advances in asymmetric A3 coupling.

Rokade BV, Barker J, Guiry PJ.

Chem Soc Rev. 2019 Sep 16;48(18):4766-4790. doi: 10.1039/c9cs00253g.

PMID:
31465045
13.

Re-Categorization of Psoriasis Severity: Delphi Consensus from the International Psoriasis Council.

Strober B, Ryan C, van de Kerkhof P, van der Walt J, Kimball AB, Barker J, Blauvelt A.

J Am Acad Dermatol. 2019 Aug 16. pii: S0190-9622(19)32573-3. doi: 10.1016/j.jaad.2019.08.026. [Epub ahead of print]

14.

Comorbid HIV infection and alcohol use disorders: Converging glutamatergic and dopaminergic mechanisms underlying neurocognitive dysfunction.

Giacometti LL, Barker JM.

Brain Res. 2019 Nov 15;1723:146390. doi: 10.1016/j.brainres.2019.146390. Epub 2019 Aug 14. Review.

PMID:
31421128
15.

Urgent Time to Allogeneic Hematopoietic Cell Transplantation: A National Survey of Transplant Physicians and Unrelated Donor Search Coordinators Facilitated by the Histocompatibility Advisory Group to the National Marrow Donor Program.

Pidala J, Mupfudze TG, Payton T, Barker J, Perales MA, Shaw BE, Fernández-Viña M, Burns LJ, Dehn J.

Biol Blood Marrow Transplant. 2019 Aug 13. pii: S1083-8791(19)30516-6. doi: 10.1016/j.bbmt.2019.08.002. [Epub ahead of print]

PMID:
31419569
16.

Electrical stimulation shifts healing/scarring towards regeneration in a rat limb amputation model.

Oliveira KMC, Barker JH, Berezikov E, Pindur L, Kynigopoulos S, Eischen-Loges M, Han Z, Bhavsar MB, Henrich D, Leppik L.

Sci Rep. 2019 Aug 7;9(1):11433. doi: 10.1038/s41598-019-47389-w.

17.

Response to: One size does not fit all-application of accelerometer thresholds in chronic disease.

Barker J, Smith Byrne K, Doherty A, Foster C, Rahimi K, Ramakrishnan R, Woodward M, Dwyer T.

Int J Epidemiol. 2019 Aug 2. pii: dyz165. doi: 10.1093/ije/dyz165. [Epub ahead of print] No abstract available.

PMID:
31373623
18.

The importance of clinical documentation improvement for Australian hospitals.

Hay P, Wilton K, Barker J, Mortley J, Cumerlato M.

Health Inf Manag. 2019 Jul 14:1833358319854185. doi: 10.1177/1833358319854185. [Epub ahead of print]

PMID:
31303061
19.

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR.

Dehn J, Spellman S, Hurley CK, Shaw BE, Barker JN, Burns LJ, Confer DL, Eapen M, Fernandez-Vina M, Hartzman R, Maiers M, Marino SR, Mueller C, Perales MA, Rajalingam R, Pidala J.

Blood. 2019 Sep 19;134(12):924-934. doi: 10.1182/blood.2019001212. Epub 2019 Jul 10. Review.

PMID:
31292117
20.

Morphologic Switch From Psoriasiform to Eczematous Dermatitis After Anti-IL-17 Therapy: A Case Series.

Lai FYX, Higgins E, Smith CH, Barker JN, Pink A.

JAMA Dermatol. 2019 Jul 10. doi: 10.1001/jamadermatol.2019.1268. [Epub ahead of print] No abstract available.

PMID:
31290949
21.

Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR).

Mahil SK, Wilson N, Dand N, Reynolds NJ, Griffiths CEM, Emsley R, Marsden A, Evans I, Warren RB, Stocken D, Barker JN, Burden AD, Smith CH; BADBIR study group and the PSORT consortium.

Br J Dermatol. 2019 Jul 8. doi: 10.1111/bjd.18333. [Epub ahead of print]

PMID:
31286471
22.

Physical activity of UK adults with chronic disease: cross sectional analysis of accelerometer measured physical activity in 96,706 UK Biobank participants.

Barker J, Smith Byrne K, Doherty A, Foster C, Rahimi K, Ramakrishnan R, Woodward M, Dwyer T.

Int J Epidemiol. 2019 Jul 5. pii: dyz148. doi: 10.1093/ije/dyz148. [Epub ahead of print] No abstract available.

PMID:
31280303
23.

Case of trileaflet mitral valve: an important differential for non-classical intracavitary gradient in suspected hypertrophic cardiomyopathy.

Barker J, Silverwood N, Gerber R.

BMJ Case Rep. 2019 Jun 18;12(6). pii: e229106. doi: 10.1136/bcr-2018-229106.

PMID:
31217211
24.

Cross-disorder analysis of schizophrenia and 19 immune-mediated diseases identifies shared genetic risk.

Pouget JG; Schizophrenia Working Group of the Psychiatric Genomics Consortium, Han B, Wu Y, Mignot E, Ollila HM, Barker J, Spain S, Dand N, Trembath R, Martin J, Mayes MD, Bossini-Castillo L, López-Isac E, Jin Y, Santorico SA, Spritz RA, Hakonarson H, Polychronakos C, Raychaudhuri S, Knight J.

Hum Mol Genet. 2019 Jun 18. pii: ddz145. doi: 10.1093/hmg/ddz145. [Epub ahead of print]

PMID:
31211845
25.

E-Cigarette Outcome Expectancies among Nationally Representative Samples of Adolescents and Young Adults.

Barker JO, Kelley DE, Noar SM, Reboussin BA, Cornacchione Ross J, Sutfin EL.

Subst Use Misuse. 2019;54(12):1970-1979. doi: 10.1080/10826084.2019.1624773. Epub 2019 Jun 12.

PMID:
31188055
26.

Early natural history of neotissue formation in tissue-engineered vascular grafts in a murine model.

Reinhardt JW, Rosado JDR, Barker JC, Lee YU, Best CA, Yi T, Zeng Q, Partida-Sanchez S, Shinoka T, Breuer CK.

Regen Med. 2019 May;14(5):389-408. doi: 10.2217/rme-2018-0133. Epub 2019 Jun 10.

PMID:
31180275
27.

Atypical wounds. Best clinical practice and challenges.

Isoherranen K, O'Brien JJ, Barker J, Dissemond J, Hafner J, Jemec GBE, Kamarachev J, Läuchli S, Montero EC, Nobbe S, Sunderkötter C, Velasco ML.

J Wound Care. 2019 Jun 1;28(Sup6):S1-S92. doi: 10.12968/jowc.2019.28.Sup6.S1. No abstract available.

PMID:
31169055
28.

Prevalence of Advanced Liver Fibrosis in Patients With Severe Psoriasis.

Maybury CM, Porter HF, Kloczko E, Duckworth M, Cotton A, Thornberry K, Dew T, Crook M, Natas S, Miquel R, Lewis CM, Wong T, Smith CH, Barker JN.

JAMA Dermatol. 2019 Jun 5. doi: 10.1001/jamadermatol.2019.0721. [Epub ahead of print]

PMID:
31166567
29.

Regarding "Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study".

Hurley CK, Spellman S, Dehn J, Barker JN, Devine S, Fernandez-Vina M, Gautreaux M, Logan B, Maiers M, Mueller C, Perales MA, Yu N, Pidala J.

Biol Blood Marrow Transplant. 2019 Aug;25(8):e268-e269. doi: 10.1016/j.bbmt.2019.05.026. Epub 2019 May 27. No abstract available.

PMID:
31145991
30.

Anti-TNF biosimilars in psoriasis: from scientific evidence to real-world experience.

Barker J, Girolomoni G, Egeberg A, Goncalves J, Pieper B, Kang T.

J Dermatolog Treat. 2019 May 16:1-7. doi: 10.1080/09546634.2019.1610553. [Epub ahead of print]

PMID:
31094242
31.

Sex Differences in Ethanol Reward Seeking Under Conflict in Mice.

Xie Q, Buck LA, Bryant KG, Barker JM.

Alcohol Clin Exp Res. 2019 Jul;43(7):1556-1566. doi: 10.1111/acer.14070. Epub 2019 May 18.

PMID:
31034618
32.

Switching from a fumaric acid ester mixture to dimethylfumarate monotherapy in psoriasis.

Warren RB, Barker JNW, Van de Kerkhof P, Reich K, Mrowietz U.

J Eur Acad Dermatol Venereol. 2019 Oct;33(10):e352-e353. doi: 10.1111/jdv.15644. Epub 2019 May 10. No abstract available.

PMID:
31033034
33.

A storytelling intervention reduces childhood caries risk behaviors among American Indian and Alaska Native mothers in Northern California.

Heaton B, Crawford AJ, Wimsatt MA, Henshaw M, Riedy CA, Barker JC, Garcia RI.

J Public Health Dent. 2019 Sep;79(3):183-187. doi: 10.1111/jphd.12318. Epub 2019 Apr 23.

PMID:
31012105
34.

CD34+ cell content of 126 341 cord blood units in the US inventory: implications for transplantation and banking.

Barker JN, Kempenich J, Kurtzberg J, Brunstein CG, Delaney C, Milano F, Politikos I, Shpall EJ, Scaradavou A, Dehn J.

Blood Adv. 2019 Apr 23;3(8):1267-1271. doi: 10.1182/bloodadvances.2018029157.

35.

Electrical stimulation-based bone fracture treatment, if it works so well why do not more surgeons use it?

Bhavsar MB, Han Z, DeCoster T, Leppik L, Costa Oliveira KM, Barker JH.

Eur J Trauma Emerg Surg. 2019 Apr 6. doi: 10.1007/s00068-019-01127-z. [Epub ahead of print] Review.

PMID:
30955053
36.

Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis.

Barker JN, Boughan K, Dahi PB, Devlin SM, Maloy MA, Naputo K, Mazis CM, Davis E, Nhaissi M, Wells D, Cooper C, Ponce DM, Kernan N, Scaradavou A, Giralt SA, Papadopoulos EB, Politikos I.

Blood Adv. 2019 Apr 9;3(7):939-944. doi: 10.1182/bloodadvances.2018028662.

37.

Expansion of patient safety regulatory requirements in community pharmacy in Canada: The Melissa Sheldrick effect?

MacKinnon NJ, Cook R, Barker JR.

Can Pharm J (Ott). 2019 Feb 17;152(2):77-80. doi: 10.1177/1715163519827981. eCollection 2019 Mar-Apr. No abstract available.

38.

Content, cost, and context: A framework for understanding human signaling systems.

Barker JL, Power EA, Heap S, Puurtinen M, Sosis R.

Evol Anthropol. 2019 Mar;28(2):86-99. doi: 10.1002/evan.21768. Epub 2019 Mar 14. Review.

PMID:
30869833
39.

What does acne genetics teach us about disease pathogenesis?

Common JEA, Barker JN, van Steensel MAM.

Br J Dermatol. 2019 Oct;181(4):665-676. doi: 10.1111/bjd.17721. Epub 2019 Mar 10. Review.

PMID:
30854635
40.

Barriers to the use of patient safety information sources by community pharmacies.

Barker JR, Boyle TC, Tay L, Bishop A, Morrison B, Murphy A, MacKinnon NJ, Murray E, Ho C.

Res Social Adm Pharm. 2019 Jul;15(7):895-901. doi: 10.1016/j.sapharm.2019.02.015. Epub 2019 Feb 27.

PMID:
30852087
41.

Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02.

Tziotzios C, Petridis C, Dand N, Ainali C, Saklatvala JR, Pullabhatla V, Onoufriadis A, Pramanik R, Baudry D, Lee SH, Wood K, Liu L, Seegobin S, Michelotti GA, Lwin SM, Christou EAA, Curtis CJ, de Rinaldis E, Saxena A, Holmes S, Harries M, Palamaras I, Cunningham F, Parkins G, Kaur M, Farrant P, McDonagh A, Messenger A, Jones J, Jolliffe V, Ali I, Ardern-Jones M, Mitchell C, Burrows N, Atkar R, Banfield C, Alexandroff A, Champagne C, Cooper HL, Vañó-Galván S, Molina-Ruiz AM, Perez NO, Patel GK, Macbeth A, Page M, Bryden A, Mowbray M, Wahie S, Armstrong K, Cooke N, Goodfield M, Man I, de Berker D, Dunnill G, Takwale A, Rao A, Siah TW, Sinclair R, Wade MS, Dlova NC, Setterfield J, Lewis F, Bhargava K, Kirkpatrick N, Estivill X, Stefanato CM, Flohr C, Spector T, Watt FM, Smith CH, Barker JN, Fenton DA, Simpson MA, McGrath JA.

Nat Commun. 2019 Mar 8;10(1):1150. doi: 10.1038/s41467-019-09117-w.

42.

Lexical frequency effects in English and Spanish word misperceptions.

Cooke M, García Lecumberri ML, Barker J, Marxer R.

J Acoust Soc Am. 2019 Feb;145(2):EL136. doi: 10.1121/1.5090196.

43.

A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis.

Yiu ZZN, Mason KJ, Barker JNWN, Hampton PJ, McElhone K, Smith CH, Warren RB, Griffiths CEM, Lunt M, Burden AD; BADBIR Study Group.

Br J Dermatol. 2019 Mar 1. doi: 10.1111/bjd.17849. [Epub ahead of print]

44.

Lower general executive function is primarily associated with trait worry: A latent variable analysis of negative thought/affect measures.

Gustavson DE, Lurquin JH, Michaelson LE, Barker JE, Carruth NP, von Bastian CC, Miyake A.

Emotion. 2019 Feb 28. doi: 10.1037/emo0000584. [Epub ahead of print]

PMID:
30816740
45.

Membrane potential (Vmem) measurements during mesenchymal stem cell (MSC) proliferation and osteogenic differentiation.

Bhavsar MB, Cato G, Hauschild A, Leppik L, Costa Oliveira KM, Eischen-Loges MJ, Barker JH.

PeerJ. 2019 Feb 8;7:e6341. doi: 10.7717/peerj.6341. eCollection 2019.

46.

Construction and Use of an Electrical Stimulation Chamber for Enhancing Osteogenic Differentiation in Mesenchymal Stem/Stromal Cells In Vitro.

Leppik L, Bhavsar MB, Oliveira KMC, Eischen-Loges M, Mobini S, Barker JH.

J Vis Exp. 2019 Jan 31;(143). doi: 10.3791/59127.

PMID:
30774122
47.

Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? A Critically Appraised Topic.

Mahil SK, McSweeney SM, Kloczko E, McGowan B, Barker JN, Smith CH.

Br J Dermatol. 2019 Feb 6. doi: 10.1111/bjd.17741. [Epub ahead of print]

PMID:
30729517
48.

Evidence for an Integrated Gene Repression Mechanism Based on mRNA Isoform Toggling in Human Cells.

Hollerer I, Barker JC, Jorgensen V, Tresenrider A, Dugast-Darzacq C, Chan LY, Darzacq X, Tjian R, Ünal E, Brar GA.

G3 (Bethesda). 2019 Apr 9;9(4):1045-1053. doi: 10.1534/g3.118.200802.

49.

Physical activity of UK adults with chronic disease: cross-sectional analysis of accelerometer-measured physical activity in 96 706 UK Biobank participants.

Barker J, Smith Byrne K, Doherty A, Foster C, Rahimi K, Ramakrishnan R, Woodward M, Dwyer T.

Int J Epidemiol. 2019 Feb 5. doi: 10.1093/ije/dyy294. [Epub ahead of print]

50.

Does continuous subcutaneous infusion of lignocaine relieve intractable pruritus associated with advanced cutaneous T-cell lymphoma? A retrospective case series review.

Norris J, Barker J, Buelens O, Spruijt O.

Palliat Med. 2019 May;33(5):552-556. doi: 10.1177/0269216319828189. Epub 2019 Feb 4.

PMID:
30712496

Supplemental Content

Loading ...
Support Center